Drug-free nasal spray could prevent COVID-19 infection, promising data show
December 3, 2020Research and Development COVID-19, Nasal Spray, auris medical
Auris Medical has revealed promising new in vitro data for AM-301, its drug-free nasal spray, showing that the product could …
Roche secures emergency FDA approval for COVID-19 antibody test
December 3, 2020Sales and Marketing COVID-19, FDA, Roche
The FDA has awarded Emergency Use Authorization to Roche’s COVID-19 test to allow users in the US to analyse the …
Pharmafile.com’s weekly COVID-19 news round-up
December 2, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Image credit: CDC, Top 5, Vaccine
EMA receives Pfizer and BioNTech’s filing for conditional approval of COVID-19 vaccine in Europe – Published on 01/12/20
FDA greenlights Gavreto for advanced or metastatic rearranged during transfection (RET)-mutant medullary thyroid cancer in over-12s
December 2, 2020Research and Development, Sales and Marketing FDA, Gavreto, Roche
The FDA has awarded accelerated approval to Roche and Blueprint Medicines’ Gavreto (pralsetinib) for the treatment of advanced or metastatic …
European approval for Janssen’s Tremfya in active psoriatic arthritis, either alone or in combo
December 2, 2020Research and Development, Sales and Marketing Europe, Janssen, Tremfya
The European Commission has authorised Janssen’s interleukin (IL)-23 inhibitor Tremfya (guselkumab) in the treatment of active psoriatic arthritis (PsA), either …
Ovid’s Angelman syndrome therapy falls short at Phase 3
December 2, 2020Research and Development Angelman syndrome, Ovid
Ovid Therapeutics has revealed disappointing results for its therapy OV101 (gaboxadol) in the treatment of Angelman syndrome, admitting that it failed …
UK becomes first nation to approve Pfizer and BioNTech’s COVID-19 vaccine
December 2, 2020Research and Development, Sales and Marketing COVID-19, Pfizer, UK, Vaccine
The UK has become the first country worldwide to authorise Pfizer and BioNTech’s promising COVID-19 vaccine, the UK Government has …
The Autumn 2020 edition of Pharmafile is available to read for free online now!
December 1, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing infectious diseases, pharmafile, rare disease, respiratory
The Autumn 2020 edition of Pharmafile is available to read for free online now! 2020 has seen almost unprecedented disruption …
Eisai and Wren Therapeutics join forces to tackle neurodegenerative synucleinopathies
December 1, 2020Manufacturing and Production, Research and Development, Sales and Marketing Eisai, Wren Therapeutics
Eisai has forged an exclusive research partnership with Wren Therapeutics to develop new approaches in tackling neurodegenerative diseases known as …
EMA receives Pfizer and BioNTech’s filing for conditional approval of COVID-19 vaccine in Europe
December 1, 2020Manufacturing and Production, Sales and Marketing BioNTech, COVID-19, EMA, Pfizer, Vaccine
Pfizer and BioNTech have officially submitted their application to secure conditional marketing authorisation to the European Medicines Agency (EMA) for …
Grünenthal buys European rights to AstraZeneca’s Crestor for a potential $350m
December 1, 2020Manufacturing and Production, Sales and Marketing AstraZeneca, Crestor, Grunenthal
Grünenthal has picked up AstraZeneca’s statin therapy Crestor (rosuvastatin), currently approved in dyslipidaemia and hypercholesterolaemia treatment, in a deal worth …
Optimise your clinical trials with Avantor Clinical Services
December 1, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2020 Campaign, Avantor, clinical trials, expertise
Serious diseases like COVID-19 put increasing pressure on researchers to find breakthrough treatments faster. Along with accelerated timelines, biopharma and …
Cabometyx scores Japanese approval for unresectable hepatocellular carcinoma patients following systemic therapy
November 30, 2020Sales and Marketing Cabometyx, Japan, Takeda
The Japanese Ministry of Health, Labor and Welfare has awarded approval to Takeda for Cabometyx (cabozantinib) as a treatment for …
Analysis confirms Moderna’s COVID-19 vaccine efficacy to be 94.1%
November 30, 2020Research and Development, Sales and Marketing COVID-19, Moderna, Vaccine
US biotech Moderna has followed up on its highly promising efficacy data for its mRNA-based COVID-19 vaccine candidate with the …
Dupixent becomes first systemic medicine approved in Europe for children with severe atopic dermatitis
November 30, 2020Sales and Marketing Dupixent, EU, Europe, Sanofi
The European Commission has moved to expand the existing authorisation of Sanofi and Regeneron’s Dupixent (dupilumab) in the European Union …
UK secures another two million COVID-19 vaccine doses from Moderna
November 30, 2020Sales and Marketing COVID-19, Moderna, UK
The UK Government has expanded upon its previous negotiations with Moderna to secure an additional two million doses of its …
Japan approves AstraZeneca’s Forxiga for chronic heart failure
November 30, 2020Sales and Marketing AstraZeneca, Forxiga
Japan’s Ministry of Health, Labour and Welfare (MHLW) has announced the authorisation of AstraZeneca’s Forxiga as a treatment for chronic …
AstraZeneca targeted by suspected North Korean hackers
November 27, 2020Medical Communications
Hackers suspected to be operating from North Korea have tried to break into the systems of AstraZeneca, two people with …
Japan approves Astellas and FibroGen’s Evrenzo for chronic kidney disease patients currently not receiving dialysis
November 27, 2020Medical Communications, Sales and Marketing Astellas, Japan, fibrogen
Japan’s Ministry of Health, Labour and Welfare (MHLW) has passed approval for Astellas and FibroGen’s Evrenzo (roxadustat) in the treatment …
New trial expected for AstraZeneca’s COVID-19 vaccine
November 27, 2020Medical Communications
AstraZeneca is expected to launch new global trials to assess the efficacy of its COVID-19 vaccine using a lower dosage. …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
